Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 2 |
2024 | 3 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Rational design and synthesis of 2,4-dichloro-6-methyl pyrimidine derivatives as potential selective EGFRT790M/L858R inhibitors for the treatment of non-small cell lung cancer.
Arch Pharm (Weinheim). 2024 May;357(5):e2300736. doi: 10.1002/ardp.202300736. Epub 2024 Feb 21.
Arch Pharm (Weinheim). 2024.
PMID: 38381049
Insights into the Overcoming EGFRDel19/T790M/C797S Mutation: A Perspective on the 2-Aryl-4-aminothienopyrimidine Backbone.
Zhang X, He J, Xu S, Fu L, Zheng P, Xu S, Pan Q, Zhu W.
Zhang X, et al.
ChemMedChem. 2024 May 2;19(9):e202300634. doi: 10.1002/cmdc.202300634. Epub 2024 Mar 7.
ChemMedChem. 2024.
PMID: 38351876
Item in Clipboard
Discovery of novel potent PI3K/mTOR dual-target inhibitors based on scaffold hopping: Design, synthesis, and antiproliferative activity.
Yang Y, Sun X, Luo L, Peng R, Yang R, Cheng Z, Lv Y, Li H, Tang Q, Zhu W, Qiao D, Xu S.
Yang Y, et al.
Arch Pharm (Weinheim). 2023 Dec;356(12):e2300403. doi: 10.1002/ardp.202300403. Epub 2023 Oct 15.
Arch Pharm (Weinheim). 2023.
PMID: 37840368
Item in Clipboard
Novel bioactive 2-phenyl-4-aminopyrimidine derivatives as EGFRDel19/T790M/C797S inhibitors for the treatment of non-small cell lung cancer.
Xu S, Zhou Z, He J, Guo J, Huang X, An Y, Pan Q, Xu S, Zhu W.
Xu S, et al.
Arch Pharm (Weinheim). 2024 Feb;357(2):e2300460. doi: 10.1002/ardp.202300460. Epub 2023 Nov 27.
Arch Pharm (Weinheim). 2024.
PMID: 38009481
Item in Clipboard
Cite
Cite